Literature DB >> 8774958

The identification of a functional nuclear localization signal in the Huntington disease protein.

D A Bessert1, K L Gutridge, J C Dunbar, L R Carlock.   

Abstract

Positional cloning has shown that the Huntington disease (HD) mutation is an expanded trinucleotide repeat in the IT15 gene. Although this mutation clearly produces the HD phenotype, the function of the Huntington disease protein remains undefined. One recent immunocytochemical study suggested that the IT15 protein preferentially localizes to the nucleus of affected neuronal cells. If this result is accurate, it could link the biochemical function of this protein to nuclear activities such as gene regulation. To examine the nuclear transport of the Huntington disease protein, we searched for basic peptide motifs that could produce nuclear localization. One peptide (RRKGKEK) was identified that is highly homologous to a consensus nuclear localization signal. When fused to the cytoplasmic reporter protein, beta-galactosidase, nuclear localization was observed in stably transformed human cell lines. In a complementary study, an anti-peptide polyclonal antibody, raised against a sequence adjacent to the putative nuclear localization sequence, detected the IT15 protein in the nucleus of human cells. These results extend and confirm the previous localization studies and identify an IT15 peptide motif that can function for nuclear localization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8774958     DOI: 10.1016/0169-328x(95)00124-b

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

2.  Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.

Authors:  F R Fusco; Q Chen; W J Lamoreaux; G Figueredo-Cardenas; Y Jiao; J A Coffman; D J Surmeier; M G Honig; L R Carlock; A Reiner
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 3.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

4.  Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice.

Authors:  A Reiner; N Del Mar; C A Meade; H Yang; I Dragatsis; S Zeitlin; D Goldowitz
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

Authors:  A J Cooper; K R Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  Mouse models of Huntington disease: variations on a theme.

Authors:  Dagmar E Ehrnhoefer; Stefanie L Butland; Mahmoud A Pouladi; Michael R Hayden
Journal:  Dis Model Mech       Date:  2009 Mar-Apr       Impact factor: 5.758

7.  Huntingtin localisation studies - a technical review.

Authors:  Alis Hughes; Lesley Jones
Journal:  PLoS Curr       Date:  2011-02-16

Review 8.  Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors.

Authors:  Amandeep Girdhar; Lin Guo
Journal:  Biology (Basel)       Date:  2022-07-04

Review 9.  Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.

Authors:  Sarah J Tabrizi; Michael D Flower; Christopher A Ross; Edward J Wild
Journal:  Nat Rev Neurol       Date:  2020-08-14       Impact factor: 42.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.